HeimTHYROCARE • NSE
add
Thyrocare Technologies Ltd
Við síðustu lokun
878,10 ₹
Dagbil
868,00 ₹ - 904,20 ₹
Árabil
571,40 ₹ - 1.055,00 ₹
Markaðsvirði
47,50 ma. INR
Meðalmagn
175,69 þ.
V/H-hlutf.
52,43
A/V-hlutfall
-
Aðalkauphöll
NSE
Viðskiptafréttir
The Washington Post
fyrir 14 klukkustundum
Markets erase April losses as jobs report fuels stock gains
1,47%
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (INR) | mar. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 1,87 ma. | 21,34% |
Rekstrarkostnaður | 602,90 m. | 61,94% |
Nettótekjur | 217,00 m. | 22,05% |
Hagnaðarhlutfall | 11,59 | 0,52% |
Hagnaður á hvern hlut | 4,16 | 17,51% |
EBITDA | 577,45 m. | 82,58% |
Virkt skatthlutfall | 54,29% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (INR) | mar. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 1,92 ma. | 31,30% |
Heildareignir | 6,93 ma. | 7,59% |
Heildarskuldir | 1,46 ma. | 25,33% |
Eigið fé alls | 5,47 ma. | — |
Útistandandi hlutabréf | 52,04 m. | — |
Eiginfjárgengi | 8,36 | — |
Arðsemi eigna | — | — |
Ávöxtun eigin fjár | 20,36% | — |
Peningaflæði
Breyting á handbæru fé
| (INR) | mar. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 217,00 m. | 22,05% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Stofnsett
1996
Höfuðstöðvar
Vefsvæði
Starfsfólk
1.693
